Piramal Pharma Share Price Target Tomorrow 2024 To 2030

Piramal Pharma Share Price Target Tomorrow 2024 To 2030

Piramal Pharma Share Price Target – Well understood by the name, Piramal is a pharmaceutical company that excels in manufacturing and delivering pharmaceutical products. It is rising on the economic ladder, slowly becoming a key player in its big contribution to manufacturing complex patron healthcare. It is gradually taking its place in the international market. 

The assessment below is a detailed view of its current share price graph, current market analysis, overall market situation, share price targets, financial projections, annual income statement, and other additional information.

Current share price graph of Piramal Pharma

Current share price graph of Piramal Pharma

Current Performance Overview For Piramal Pharma Share Price

  • Open: 227. 95
  • 52-Week High: 239.45 INR
  • 52-Week Low: 87.55 INR
  • Current Price: 232.80 INR
  • Market Capitalization: 31,360 Crores INR
  • P/E Ratio: 1,129.46
  • Dividend Yield: 0.046%

Piramal Pharma Share Price Financial Projections From 2024-2030

The following table shows the tabular form of financial projections (share price targets) from 2024-2030.

Year Share Price Target
2024 ₹250 
2025 ₹389
2026 ₹514 
2027 ₹647
2028 ₹797 
2029 ₹947
2030 ₹1102

Shareholding Pattern For Piramal Pharma Share Price

  • Promoters: 34.95%
  • Foreign Institutions: 31.40%
  • Retail and Others: 20.68%
  • Mutual Funds: 10.12%
  • Other Domestic Institutions: 2.84%

Annual Income Statement Of Piramal Pharma Share Price

The following is a graphical representation of the annual income statement of Piramal Share Price-

Annual Income Statement Of Piramal Pharma Share Price

The following is a tabular representation of Piramal Pharma Share Price for easier understanding-

(INR) 2024 Y/Y change
Revenue 81.71B 15.39%
Operating Expense 44.49B 7.09%
Net income 178.20M 109.56%
Net profit margin 0.22 108.37%
Earnings per share 0.19 112.57%
EBITDA 11.39B 97.62%
Effective tax rate 90.06%

Key Drivers For Piramal’s Growth From 2024-2030

  • Increased call for complex sanctorium generics
  • Growth in customer healthcare
  • Progressive partnerships and acquisitions.

Leave a Comment

Your email address will not be published. Required fields are marked *